Michael Mitchell
University of Massachusetts Medical School
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael Mitchell.
Clinical Infectious Diseases | 1999
Kimberly Gerstadt; Jennifer S. Daly; Michael Mitchell; Mireya Wessolossky; Sarah H. Cheeseman
virus DNA in cerebrospinal fluid from immunocompetent individuals with brain disorders. Microbiologica 1998;21:77–9. 8. Studahl M, Bergström T, Hagberg L. Acute viral encephalitis in adults— a prospective study. Scand J Infect Dis 1998;30:215–20. 9. Tang YW, Espy MJ, Persing DH, Smith TF. Molecular evidence and clinical significance of herpesvirus coinfection in the central nervous system. J Clin Microbiol 1997;35:2869–72.
Pediatric Pulmonology | 2009
David Carlson; Elizabeth McKeen; Michael Mitchell; Brenda Torres; Richard B. Parad; Anne Marie Comeau; Brian O'Sullivan
The purpose of this preliminary study was to determine normal oropharyngeal flora in healthy, non‐CF infants in order to help care givers better interpret culture results obtained from infants with CF.
Journal of Clinical Apheresis | 2017
Yong Zhao; Brian Alexander; Jeffrey A. Bailey; Linda Welch; Mindy Greene; Michelle Vauthrin; Michael Mitchell; Robert Weinstein
Apheresis has been used to lower the parasite burden of patients with Loa loa infection, but there are no reports regarding how to do this using modern, continuous flow equipment with a currently available program. A 23‐year‐old female refugee from Cameroon with known Loa loa infection presented to our Emergency Department with acute mental status changes and a picture of encephalitis. Lumbar puncture revealed Loa loa in her cerebrospinal fluid. Her midday blood microfilaria count was 15,000/mL. Because treatment with diethylcarbamazine was under consideration, we were asked to lower her parasite burden using apheresis. One single 2‐total blood volume apheresis using the mononuclear cell program (without hydroxyethyl starch) on a COBE® Spectra Apheresis System decreased the microfilarial load from 15,000/mL to 10,666/mL, a 29% reduction. J. Clin. Apheresis 32:200–202, 2017.
American Journal of Tropical Medicine and Hygiene | 2017
Ahmed Al Hammadi; Michael Mitchell; George M. Abraham; Jennifer P. Wang
We present a case of a primigravid woman who presented with Plasmodium falciparum nearly 3 years after she last visited a malaria-endemic region. We review the literature to identify case reports of recrudescent P. falciparum malaria during pregnancy, including those with prolonged latency. Reports of recrudescence of P. falciparum during pregnancy are limited. Plasmodium falciparum infection can persist for years. Recrudescence can occur with waning of immunity following departure from endemic areas. Pregnancy, particularly the primigravid state, is a risk factor for severe infection.
Chest | 2017
Anna M. Civitarese; Eric Ruggieri; J. Matthias Walz; Deborah Ann Mack; Stephen O. Heard; Michael Mitchell; Craig M. Lilly; Karen Landry; Richard T. Ellison
Background The rates of central line‐associated bloodstream infections (CLABSIs) in U.S. ICUs have decreased significantly, and a parallel reduction in the rates of total hospital‐onset bacteremias in these units should also be expected. We report 10‐year trends for total hospital‐onset ICU‐associated bacteremias at a tertiary‐care academic medical center. Methods This was a retrospective analysis of all positive‐result blood cultures among patients admitted to seven adult ICUs for fiscal year 2005 (FY2005) through FY2014 according to Centers for Disease Control and Prevention National Healthcare Safety Network definitions. The rate of change for primary and secondary hospital‐onset BSIs was determined, as was the distribution of organisms responsible for these BSIs. Data from three medical, two general surgical, one combined neurosurgical/trauma, and one cardiac/cardiac surgery adult ICU were analyzed. Results Across all ICUs, the rates of primary BSIs progressively fell from 2.11/1,000 patient days in FY2005 to 0.32/1,000 patient days in FY2014; an 85.0% decrease (P < .0001). Secondary BSIs also progressively decreased from 3.56/1,000 to 0.66/1,000 patient days; an 81.4% decrease (P < .0001). The decrease in BSI rates remained significant after controlling for the number of blood cultures obtained and patient acuity. Conclusions An increased focus on reducing hospital‐onset infections at the academic medical center since 2005, including multimodal multidisciplinary efforts to prevent central line‐associated BSIs, pneumonia, Clostridium difficile disease, surgical site infections, and urinary tract infections, was associated with progressive and sustained decreases for both primary and secondary hospital‐onset BSIs.
JAMA Internal Medicine | 1999
David Anderson; Philip S. Wells; Ian G. Stiell; Bruce MacLeod; Martin Simms; Lisa Gray; K. Sue Robinson; John Bormanis; Michael Mitchell; Bernard Lewandowski; Gordon Flowerdew
The Lancet | 1998
Philip S. Wells; David Anderson; Janis Bormanis; Fred Guy; Michael Mitchell; Bernard Lewandowski
Canadian Journal of Surgery | 1998
Robinson Ks; Anderson Dr; Michael Gross; David Petrie; Ross Leighton; Stanish W; David Alexander; Michael Mitchell; Mason W; Flemming B; Fairhurst-Vaughan M; Gent M
Canadian Journal of Surgery | 2001
David Alexander; Neil Manson; Michael Mitchell
Archive | 2016
David Anderson; Philip S. Wells; Ian G. Stiell; Bruce MacLeod; Martin Simms; Lisa Gray; K. Sue Robinson; John Bormanis; Michael Mitchell; Bernard Lewandowski; Gordon Flowerdew